Navigation Links
Abbott Annual Meeting Highlights Outstanding 2008 Results, Continued Strong Outlook
Date:4/24/2009

ABBOTT PARK, Ill., April 24 /PRNewswire-FirstCall/ -- Abbott's diversified portfolio of businesses generated industry-leading results across the company in 2008 and remain strong and focused for the future, Chairman and Chief Executive Officer Miles D. White told shareholders today at the company's annual meeting.

"Abbott had a truly outstanding year in 2008 across all of our major businesses - medical devices, nutritional products, diagnostics and pharmaceuticals," said Mr. White. "We delivered on our strategic, operational and financial goals, strengthened our leadership positions across our range of global businesses, and we executed a record nine major new product launches."

Value of Diversity

Balanced growth across the company's major businesses drove another year of double-digit ongoing earnings growth in 2008. Abbott's business portfolio, enhanced by the February 2009 acquisition of Advanced Medical Optics, a global leader in vision care and surgery, generates sustainable growth, particularly in the current economic environment.

Over the last one, three and five years, Abbott's total return, which includes stock price performance and dividends, has significantly outperformed the S&P 500 Index and the majority of its health care peers. Abbott's top-tier total return is due, in part, to the company's 36th consecutive annual increase in its cash dividend, amid widespread dividend reductions across industries. This year, Abbott increased its dividend by 11 percent.

"Our company remains strong, focused, and ready for the future," said Mr. White. "The steps we've taken in recent years to strengthen our company with a diverse mix of businesses stand us in very good stead for these times.
'/>"/>

SOURCE Abbott Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009
2. Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
3. Abbott Hosts Conference Call for First-Quarter Earnings
4. Abbott Launches VOYAGER(TM) NC Coronary Balloon Catheter
5. Abbott to Present at Cowen Annual Health Care Conference
6. Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary
7. Abbott Completes Acquisition of Advanced Medical Optics
8. Abbott Opens New Pediatric Nutrition Manufacturing Facility in Singapore
9. Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics
10. Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics
11. Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Meaningful long-term survival is possible for selected patients ... treated with cytoreductive surgery with Hyperthermic IntraPeritoneal Chemotherapy, ... physicians at Wake Forest Baptist Medical Center. , ... experience with cytoreductive surgery and HIPEC, said lead ... 20 years, worth of patient data shows that ...
(Date:4/17/2014)... per cent of Canadians surveyed said they would participate ... specific number of genetic conditions, only 80 per cent ... that would sequence their newborns, genomes.,Most newborns in North ... day or two of life in which a tiny ... tested for about five to 54 conditions, depending on ...
(Date:4/17/2014)... have called for more research to be carried ... in sub-Saharan Africa. In a paper in ... Stothard, working with colleagues in the department of ... in Cleveland Ohio, University of Cambridge and the ... the joint burden of HIV/AIDS and schistosomiasis of ...
(Date:4/16/2014)... ANTONIO, Texas (April 16, 2014) A team that includes ... Texas Health Science Center at San Antonio, Johns Hopkins University ... that helps a common fungus to infect the body. , ... diaper rashes and oral thrush, and is the most common ...
(Date:4/15/2014)... nearly half of all injuries aboard commercial freezer-trawlers and ... operating off the coast of Alaska, new research from ... and others aboard the two types of vessels could ... methods used in the study could help identify and ...
Breaking Medicine News(10 mins):Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:More research called for into HIV and schistosomiasis coinfection in African children 2Health News:Changes in processing, handling could reduce commercial fishing injuries 2
... skilled negotiators when it comes to relationships and the ... of Gothenburg, Sweden. The thesis examines what children ... use. The results show that young children are skilled ... children learn, through play, which negotiation strategies are appropriate ...
... Findings worrisome because thyroid hormones play critical role in ... News) -- Exposure to flame-retardant chemicals may reduce a ... a critical role in fetal brain development, a new ... are used in a large number of consumer products, ...
... and Dora to market treats should be banned, researcher ... cartoon characters are influencing the taste preferences of very ... new study suggests. , Researchers found that the branding ... Dora the Explorer drives preschoolers to choose higher-calorie, less ...
... ... you might hope to want or need for the sunny weather to come! , ... London, UK (PRWEB) June 19, 2010 -- The summer is pretty much ... best. Fear not, for anyone stuck in London without so much as a grain of sand in ...
... ... Horizon Healthcare Services, Inc. to Put Evidence-Based Medicine into Practice with Via Oncology Pathways ... Pittsburgh ... will continue to improve as a result of wider application of Via Oncology™ Pathways, ...
... ... form of release and expression, and now it has been fine-tuned to deliver mental rejuvenation ... ... this world, it can be difficult for the average person to relax or even get ...
Cached Medicine News:Health News:Young children are skilled negotiators 2Health News:Flame Retardant May Up Risk of Thyroid Problems in Pregnancy 2Health News:Cartoon Characters Sell Kids on Unhealthy Foods 2Health News:Cartoon Characters Sell Kids on Unhealthy Foods 3Health News:Summer is Here - The Best Value Luxury Manicures, Spa Packages and Spa Waxing from Kuno Tierra, Mayfair Spa 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 2Health News:Hematology-Oncology Associates of Northern New Jersey (HOANNJ) Joins Effort to Improve Cancer Care with Via Oncology™ Pathways 3Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 2Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 3Health News:Reinvent your Mental State With Brainwave Entrainment Relaxation Music 4
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... WORTH, Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ...
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2
... Watson Pharmaceuticals, Inc. (NYSE: WPI ), a ... intends to release its first quarter 2011 financial results on ... U.S. financial markets.  The Company will also host a conference ... 27, 2011 to discuss its financial results and provide an ...
... RESMED INC. (NYSE: RMD ), announced today that ... for the third quarter and nine months of fiscal year ... results will be issued after 1:00 p.m. Pacific Time and ... review its results, market trends, and future outlook. ...
Cached Medicine Technology:Watson to Host Conference Call and Webcast to Discuss First Quarter 2011 Earnings 2ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: